Xiaoxiao Gao

Wuhan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Temporal transcriptomics identifies early-response and infection-condition-specific modules guiding host-directed anti-EBOV therapeutics.

Temporal transcriptomics identifies early-response and infection-condition-specific modules guiding host-directed anti-EBOV therapeutics.

Journal: Microbiology spectrum
Published: April 30, 2026

Optimised Neutralisation Strategies for Validating the Virucidal Efficacy of Micro-Chem Plus™ Against High-Containment Negative-Sense RNA Viruses.

Optimised Neutralisation Strategies for Validating the Virucidal Efficacy of Micro-Chem Plus™ Against High-Containment Negative-Sense RNA Viruses.

Journal: Viruses
Published: October 02, 2025

Thermal tolerance and inactivation of Ebola virus.

Thermal tolerance and inactivation of Ebola virus.

Journal: Virologica Sinica
Published: June 25, 2024

MiR-320 inhibits PRRSV replication by targeting PRRSV ORF6 and porcine CEBPB.

MiR-320 inhibits PRRSV replication by targeting PRRSV ORF6 and porcine CEBPB.

Journal: Veterinary research
Published: November 12, 2023

miRNA let-7 family regulated by NEAT1 and ARID3A/NF-κB inhibits PRRSV-2 replication in vitro and in vivo.

miRNA let-7 family regulated by NEAT1 and ARID3A/NF-κB inhibits PRRSV-2 replication in vitro and in vivo.

Journal: PLoS pathogens
Published: April 28, 2022

RNF185 regulates proteostasis in Ebolavirus infection by crosstalk between the calnexin cycle, ERAD, and reticulophagy.

RNF185 regulates proteostasis in Ebolavirus infection by crosstalk between the calnexin cycle, ERAD, and reticulophagy.

Journal: Nature communications
Published: April 07, 2022

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.

Journal: Frontiers in immunology
Published: March 17, 2022

Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection.

Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection.

Journal: Virologica Sinica
Published: August 20, 2021

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.

Journal: EClinicalMedicine
Published: May 15, 2021

RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates.

RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates.

Journal: Cell discovery
Published: April 27, 2021

Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics.

Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics.

Journal: Nature communications
Published: September 04, 2020

A serological survey of SARS-CoV-2 in cat in Wuhan.

A serological survey of SARS-CoV-2 in cat in Wuhan.

Journal: Emerging microbes & infections
Published: September 02, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026